background
differ
clinic
present
outcom
among
patient
infect
pandem
influenza
compar
respiratori
virus
fulli
elucid
viral
respiratori
ill
respons
larg
number
hospit
admiss
year
lead
substanti
morbid
mortal
etiolog
agent
includ
divers
group
virus
influenza
respons
intermitt
pandem
reassort
swineorigin
human
strain
led
circul
signific
increas
hospit
admiss
influenza
season
time
identif
influenza
import
administr
neuraminidas
inhibitor
may
limit
durat
sever
ill
given
earli
rapid
test
found
insensit
diagnosi
unabl
subtyp
influenza
viru
molecular
techniqu
replac
test
avail
expens
technic
train
limit
widespread
use
technolog
therefor
mani
clinician
reli
clinic
symptom
diagnos
influenza
pandem
classic
influenzalik
ill
ili
defin
fever
cough
andor
sore
throat
often
use
distinguish
influenza
respiratori
virus
howev
virus
respiratori
syncyti
viru
rsv
ab
rhinoviru
parainfluenza
adenoviru
metapneumoviru
coronaviru
caus
similar
ill
circul
time
influenza
use
ili
symptom
diagnos
influenza
neither
sensit
specif
symptom
report
pandem
includ
gastrointestin
complaint
leukopenia
elev
aminotransferas
level
thrombocytopenia
laboratori
abnorm
although
clinic
characterist
infect
may
similar
season
influenza
scant
data
literatur
compar
respiratori
virus
inabl
reliabl
diagnos
viral
respiratori
infect
influenza
often
lead
coverag
possibl
bacteri
etiolog
overus
antibiot
without
consequ
lead
complic
includ
clostridium
difficil
infect
high
rate
resist
thu
accur
diagnosi
influenza
respiratori
viral
infect
import
avoid
overus
antibacteri
agent
direct
appropri
antivir
therapi
respons
diagnost
challeng
present
influenza
infect
hospit
system
institut
polymeras
chain
reaction
pcr
base
molecular
panel
abl
identifi
differ
respiratori
virus
aim
studi
examin
differ
clinic
laboratori
radiograph
find
respiratori
virus
goal
assist
clinician
effect
diagnos
treat
knowledg
first
studi
directli
compar
clinic
paramet
respiratori
virus
use
sensit
molecular
diagnost
methodolog
larg
cohort
peak
season
rvp
sampl
collect
inpati
sampl
patient
year
sampl
year
sampl
year
sixhundr
fifteen
patient
posit
result
includ
final
analysi
figur
mean
age
year
rang
year
fortyseven
percent
patient
anoth
respiratori
viru
rhinoviru
second
preval
popul
analyz
tabl
fewer
patient
age
five
year
compar
virus
individu
less
like
cardiac
comorbid
malign
admit
nurs
home
individu
like
report
sick
contact
use
tobacco
individu
like
present
follow
symptom
compar
respiratori
virus
subject
fever
chill
sore
throat
nausea
vomit
abdomin
pain
weak
fatigu
headach
myalgia
chest
pain
patient
respiratori
virus
like
present
chang
mental
statu
includ
dizzi
lethargi
tabl
present
emerg
room
patient
exhibit
higher
maximum
temperatur
lower
maximum
heart
rate
respiratori
rate
systol
blood
pressur
oxygen
satur
tabl
patient
like
lower
white
blood
count
platelet
count
potassium
level
altern
patient
like
higher
hemoglobinhematocrit
albumin
level
patient
receiv
chest
radiograph
greater
number
patient
acut
find
compar
respiratori
virus
tabl
respiratori
virus
like
interstiti
opac
consist
viral
infect
chest
radiograph
thirti
percent
patient
chest
radiograph
focal
multifoc
airspac
find
patient
receiv
oseltamivir
half
receiv
antibacteri
agent
onethird
receiv
steroid
tabl
total
cohort
sputum
sampl
posit
potenti
pathogen
myalgia
arthralgia
vomit
diarrhea
microorgan
fortyfour
percent
patient
evid
acut
diseas
interstiti
opac
indic
viral
infect
chest
radiograph
receiv
antibacteri
agent
fortysix
percent
total
cohort
blood
sent
cultur
hospit
grew
potenti
pathogen
microb
ie
coagulaseneg
staphylococci
potenti
skin
contamin
exclud
twelv
percent
total
cohort
legionella
urin
antigen
test
perform
neg
differ
patient
infect
anoth
respiratori
virus
regard
admiss
intens
care
unit
use
pressor
requir
intub
tabl
howev
individu
like
requir
bilevel
posit
airway
pressur
ventil
individu
respiratori
virus
like
receiv
inhal
bronchodil
nebul
therapi
emerg
depart
seven
patient
cohort
die
individu
like
infect
vs
patient
cough
presenc
subject
feverchil
independ
increas
likelihood
infect
tabl
patient
cough
gastrointestin
complaint
subject
feverchil
independ
increas
likelihood
use
fever
alon
rais
likelihood
influenza
infect
versu
anoth
respiratori
viru
use
age
covari
patient
year
age
highest
likelihood
present
compar
age
group
ageadjust
analysi
perform
assess
factor
found
significantli
impact
likelihood
patient
intub
patient
viral
respiratori
infect
diagnosi
influenza
import
provid
time
effici
treatment
neuraminidas
inhibitor
rapid
antigen
test
insensit
diagnosi
influenza
pandem
season
furthermor
test
could
distinguish
differ
influenza
subtyp
season
influenza
resist
oseltamivir
wherea
make
critic
distinct
state
public
health
lab
cdcbase
pcr
assay
distinguish
influenza
subtyp
fdaclear
product
clinic
laboratori
delay
therefor
mani
institut
includ
implement
molecularbas
test
diagnos
influenza
luminex
xtag
rvp
highli
sensit
abl
distinguish
virus
caus
respiratori
infect
includ
differ
influenza
subtyp
introduct
effect
molecular
test
one
goal
effici
use
antimicrobi
reduct
unnecessari
antibiot
use
despit
rel
rapid
turnaround
time
pcrbase
test
greater
half
patient
cohort
document
viral
infect
receiv
antibacteri
agent
presum
empir
coverag
bacteri
pneumonia
furthermor
almost
half
patient
without
influenza
receiv
oseltamivir
implement
rapid
diagnost
test
respiratori
pathogen
alon
may
limit
antibiot
use
without
intervent
data
suggest
overus
antibacteri
antivir
agent
opportun
robust
antimicrobi
stewardship
program
clinic
characterist
hospit
patient
variabl
fever
cough
two
criteria
ili
often
occur
influenza
patient
although
patient
present
fever
sore
throat
compar
virus
popul
differ
enough
make
firm
clinic
diagnosi
influenza
furthermor
signific
differ
cough
alon
patient
infect
respiratori
virus
howev
fever
cough
gastrointestin
symptom
increas
likelihood
almost
pediatr
popul
may
use
preliminari
guid
prompt
clinician
treat
influenza
infect
chest
radiograph
may
use
diagnos
superimpos
bacteri
infect
airspac
diseas
observ
often
patient
noninfluenza
virus
chest
radiograph
find
distinguish
influenza
infect
half
patient
nonspecif
find
chest
radiograph
previous
report
studi
support
previou
find
tend
infect
younger
adult
spare
elderli
young
children
found
lower
rate
influenza
nurs
home
patient
reflect
age
distribut
die
hospit
mani
comorbid
previous
report
contrast
studi
find
high
infect
mortal
rate
pregnanc
studi
underpow
due
low
number
pregnant
women
cohort
mortal
rate
hospit
patient
infect
cohort
lower
report
despit
significantli
higher
mortal
associ
respiratori
viral
infect
highlight
import
accur
diagnosi
earli
treatment
influenza
infect
asid
retrospect
natur
studi
potenti
limit
small
number
pregnant
women
like
due
presenc
neighbor
obstetr
gynecolog
hospit
second
limit
time
period
patient
present
ili
evalu
week
peak
pandem
wherea
typic
respiratori
season
would
sever
month
includ
greater
varieti
virus
especi
pediatr
popul
fact
data
shown
indic
pandem
wave
institut
typic
peak
rsv
metapneumoviru
parainfluenza
virus
follow
presenc
much
like
rest
countri
third
limit
confirmatori
test
perform
nonsubtyp
influenza
virus
howev
recent
literatur
suggest
nonsubtyp
influenza
identifi
xtag
rvp
misinterpret
uncommon
addit
initi
investig
larg
number
strain
earli
pandem
cdc
pcr
assay
confirm
find
mani
prior
studi
assess
clinic
characterist
patient
influenza
compar
individu
respiratori
test
neg
influenza
delin
without
influenza
posit
anoth
viru
set
compar
pandem
influenza
respiratori
virus
patient
ili
knowledg
result
provid
first
comparison
clinic
characterist
common
respiratori
virus
specif
clinic
present
could
confirm
patient
cough
gastrointestin
complaint
presenc
subject
fever
andor
chill
increas
likelihood
infect
versu
anoth
viru
respiratori
infect
infect
often
result
death
compar
respiratori
virus
treat
aggress
support
measur
antivir
medic
despit
use
rvp
test
mani
influenzainfect
patient
receiv
antibacteri
agent
mani
patient
without
influenza
receiv
antivir
use
highli
accur
rvp
conjunct
robust
antimicrobi
stewardship
program
necessari
assur
prudent
antibacteri
antivir
agent
use
futur
studi
approv
rhode
island
hospit
institut
review
board
waiver
inform
consent
obtain
onset
studi
result
nasopharyng
swab
specimen
subsequ
hospit
hospit
system
consist
rhode
island
hospit
tertiari
care
center
licens
bed
includ
hasbro
children
hospit
well
miriam
newport
bradley
hospit
licens
bed
respect
respiratori
specimen
process
microbiolog
facil
rhode
island
hospit
panel
detect
influenza
ab
nonsubtyp
consist
respiratori
syncyti
viru
b
adenoviru
metapneumoviru
rhinovirusenteroviru
parainfluenza
coronavirus
panel
determin
influenza
season
human
influenza
season
human
influenza
nonsubtyp
influenza
viru
consist
rhode
island
depart
health
doh
confirm
initi
specimen
detect
xtag
rvp
nonsubtyp
influenza
util
primer
probe
distribut
center
diseas
control
prevent
cdc
thu
subsequ
nonsubtyp
influenza
detect
rvp
report
medic
record
case
review
initi
chest
radiograph
subsequ
chest
ct
review
interpret
independ
three
boardcertifi
radiologist
consensus
find
reach
logist
regress
use
examin
relationship
variabl
patient
test
posit
compar
patient
test
posit
differ
respiratori
viru
subsequ
seri
multipl
logist
regress
construct
base
integr
result
previou
literatur
logist
regress
result
individu
interact
variabl
check
retain
arriv
final
model
special
effort
place
use
symptom
clinic
inform
colinear
predictor
minim
form
theoret
clinic
guid
composit
need
predictor
test
interact
differ
age
categori
year
year
year
older
regard
predict
logist
regress
model
includ
main
effect
predictor
age
interact
two
statist
signific
interact
detect
simpl
effect
predictor
describ
term
effect
within
age
categori
significantli
interact
age
describ
term
main
effect
